Pneumococcal synergism
(Unterschied zwischen Versionen)
| Zeile 3: | Zeile 3: | ||
Pneumococcal colonization means synergism with sars cov2 ad disease expression. | Pneumococcal colonization means synergism with sars cov2 ad disease expression. | ||
13-valent pneumococcal vaccination reduces death/severity/incidence by some 30 percent, upto 90 days preexposure to antibiotics similar. | 13-valent pneumococcal vaccination reduces death/severity/incidence by some 30 percent, upto 90 days preexposure to antibiotics similar. | ||
| − | 13-valent vaccination reduces surface colonization | + | 13-valent vaccination reduces surface colonization by pneumococci, 23 valent does not. |
---- | ---- | ||
index paper is | index paper is | ||
Version vom 25. April 2021, 17:29 Uhr
| Immunology |
Pneumococcal colonization means synergism with sars cov2 ad disease expression. 13-valent pneumococcal vaccination reduces death/severity/incidence by some 30 percent, upto 90 days preexposure to antibiotics similar. 13-valent vaccination reduces surface colonization by pneumococci, 23 valent does not.
index paper is
| 33693636 2021. Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract |
until further humanized work by me,
| living current stringent pubmed readout on covid19 & pneumococci |
